I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Phase III trial of standard versus dose-intensified doxorub..:
Fayette, Jérôme
;
Penel, Nicolas
;
Chevreau, Christine
...
Investigational New Drugs. 27 (2009) 5 - p. 482-489 , 2009
Link:
https://doi.org/10.1007/s10637-008-9217-1
RT Journal T1
Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma
UL https://suche.suub.uni-bremen.de/peid=cr-10.1007_s10637-008-9217-1&Exemplar=1&LAN=DE A1 Fayette, Jérôme A1 Penel, Nicolas A1 Chevreau, Christine A1 Blay, Jean-Yves A1 Cupissol, Didier A1 Thyss, Antoine A1 Guillemet, Cécile A1 Rios, Maria A1 Rolland, Frédéric A1 Fargeot, Pierre A1 Bay, Jacques Olivier A1 Mathoulin-Pelissier, Simone A1 Coindre, Jean Michel A1 Bui-Nguyen, Binh PB Springer Science and Business Media LLC YR 2009 SN 0167-6997 SN 1573-0646 JF Investigational New Drugs VO 27 IS 5 SP 482 OP 489 LK http://dx.doi.org/https://doi.org/10.1007/s10637-008-9217-1 DO https://doi.org/10.1007/s10637-008-9217-1 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)